Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of autologous bone marrow mononuclear cells for pressure ulcers and fistulous tracts in spinal cord injured patients
2008-003015-12Phase 2Terminated
- Sponsor
- Unidad de Trasplantes y Terapia Celular del Hospital Universitario Central de Asturias
- Start
- Mar 2009
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous bone marrow-derived mononuclear cell in decubitus ulcer and fistula, sponsored by Unidad de Trasplantes y Terapia Celular del Hospital Universitario Central de Asturias. Primary endpoints: Ulcer or fistula healing and closure after treatment, Safety and feasibility of injection and 1 more. Started Mar 2009; status: terminated.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
decubitus ulcerfistula
Beyond the preview
Go deeper on 2008-003015-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003015-12.